ALTANA PHARMA AG.-COMPANY REPORT

28 page report published Jan 10, 2007
Price $41,860.00, add to your cart

This report is also available for purchase on a per-page basis.
  
Report Overview
 
Purchase by Section
 
Search Inside
 
About TF Market Research

...products in therapeutics and OTC medication. It also manufactures and markets diagnostic products for imaging technologies and self -medication products. Its aim is to improve the quality of life of patients by developing innovative drugs which enable them to lead a more active, longer, and healthier life. It is a pharmaceutical division of Altana. The was founded in #### as Byk, then in #### Byk merged with Paul Gulden & Co. forming Byk -Guldenwerke Chemische Fabrick. Then in #### Altana was created as a strategic management holding company with the Pharmaceutical Division, ALTANA Pharma based in Konstanz. ALTANA Pharma's main areas of research are focused on three indications: Gastroenterology department is focused on new approaches in the field of gastrointestinal diseases. The indication group Respiration/Inflammation conducts research in the fields of inflammatory processes, especially in respiratory diseases such as asthma and chronic obstructive lung disease (COPD). The...

Source: LIFE SCIENCE ANALYTICS
Company: ALTANA
Geographic Regions: EUROPE , GERMANY , WESTERN EUROPE REGION
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Description11
PRODUCT GLANCE21
MANAGEMENT PROFILE191
RECENT UPDATES1910
Disclosure281

Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $41,860.00
$  £  



More Market Research

Search all our Market Research from one place.


  Get FREE Research

Sign up here to receive email alerts for FREE Research from Alacra Partners!


  Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.